Reinsurance Group of America (RGA) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The annual meeting is scheduled for May 21, 2025, with a record date of April 4, 2025, and 66,085,772 shares eligible to vote.
Key business items include director elections, say-on-pay, approval of amended stock plans, and auditor ratification.
2024 saw record adjusted operating income per share ($22.57), a 15.4% adjusted operating ROE, and $1.68B deployed into in-force block transactions.
Tony Cheng became CEO on January 1, 2024; Axel André was appointed CFO in August 2024.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of all directors for a one-year term, (2) advisory vote on executive compensation, (3) approval of amended Flexible Stock Plan, (4) approval of amended Phantom Stock Plan for Directors, (5) ratification of Deloitte & Touche as auditor, and (6) other business.
Board recommends voting FOR all proposals.
All proposals require a majority of shares present or represented by proxy to pass.
Board of directors and corporate governance
Board consists of 12 members (11 independent), with an average tenure of 3.6 years and average age of 62.
41.7% gender and racial/ethnic diversity.
All committees are fully independent; annual director elections and majority voting are in place.
Board skills include governance, financial literacy, risk management, technology, and sustainability.
Board and committee assessments are conducted regularly, with an independent consultant engaged every third year.
Latest events from Reinsurance Group of America
- Record adjusted operating income and ROE, with strong premium growth and capital deployment.RGA
Q3 20249 Jul 2026 - Q1 2025 EPS $5.66, ROE 15%, net income $288M, strong capital, major reinsurance deal pending.RGA
Q1 20258 Jul 2026 - Record financials and innovation support double-digit EPS growth and ROE targets.RGA
Investor Day 20241 Jul 2026 - Q1 2026 EPS $6.97, 16.2% ROE, strong growth, favorable claims, and robust capital.RGA
Q1 202614 May 2026 - Shareholders will vote on directors, executive pay, ESPP changes, auditor ratification, and strong board/ESG oversight.RGA
Proxy filing9 Apr 2026 - Record earnings, strong premium growth, and new share repurchase authorization.RGA
Q4 20256 Feb 2026 - Adjusted operating EPS hit $5.48, ROE 15.3%, and $307M deployed into in-force transactions.RGA
Q2 20242 Feb 2026 - Record operating income, capital deployment, and higher ROE targets highlight strong growth.RGA
Q4 20248 Jan 2026 - RGA to reinsure $32B of life liabilities, deploying $1.5B and targeting $200M annual pre-tax income.RGA
Investor Update7 Jan 2026